v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities:    
Net Income (Loss) $ (242,697) $ (1,249,465)
Adjustments to Reconcile Net Income (Loss) to Net Cash Flows from Operating Activities:    
Reserve for uncollectible receivable 196,200
Expiration of produced and licensed costs 150,834
Stock option expense 306,030
Commons stock issued for services 110,000
Preferred stock redeemed in exchange for assets (42,642)
Note payable converted to equity (5,754)
Financing costs paid in shares of common stock 23,504
Amortization expense 11,667 11,667
Change in operating assets and liabilities:    
Accounts receivable 1,028,184 29,674
Prepaid expenses 21,694 (14,767)
Receivables - related party 4,086
Loans receivable, film financing arrangements
Produced and licensed costs (875,000) (1,200)
Cash overdraft 767 (21)
Accounts payable and accrued expenses (6,035) 248,453
Interest payable - related parties (6,654) 10,523
Interest payable - EIDL loan (866) (4,144)
Deferred revenue
Net Cash Flows from Operating Activities (51,190) (244,772)
Cash Flows from Investing Activities:    
Intangible assets
Net Cash Flows from Investing Activities
Cash Flows from Financing Activities:    
Proceeds from issuance of note payable
Proceeds from debt borrowings - related parties 2,626 259,906
Repayment of debt borrowings - related parties (130,310) (15,080)
Proceeds from commercial line of credit 1,050
Repayments on commercial line of credit
Proceeds from note payable 203,750
Repayment of note payable (25,000)
Proceeds from sale of Common Stock
Net Cash Flows from Financing Activities 51,066 245,876
Net Increase in Cash and Cash Equivalents (124) 1,104
Cash and Cash Equivalents, Beginning of Period 124
Cash and Cash Equivalents, End of Period 1,104
Non-cash Financing and Investing Activities:    
Notes payable converted to Common Stock 5,754
Financing costs paid in Common Stock $ 23,504